These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2448657

  • 1. A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851.
    Ginsberg SJ, Anderson JR, Gottlieb AJ, Bloomfield CD, Norton L, Barcos M, Holland JF.
    NCI Monogr; 1987; (5):77-80. PubMed ID: 2448657
    [Abstract] [Full Text] [Related]

  • 2. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN, Cadman EC, Nerenberg MI, Chen M, Bertino JR, Farber LR, Prosnitz LR.
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [Abstract] [Full Text] [Related]

  • 3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 4. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA.
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [Abstract] [Full Text] [Related]

  • 5. A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.
    Gottlieb AJ, Anderson JR, Ginsberg SJ, Bloomfield CD, Norton L, Barcos M, Peterson BA, Nissen N, Henderson ES, Holland JF.
    Cancer; 1990 Nov 01; 66(9):1888-96. PubMed ID: 1699653
    [Abstract] [Full Text] [Related]

  • 6. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG, Ghirardelli ML, Avanzini P, Baldini L, Quarta G, Stelitano C, Broglia C, Loni C, Silingardi V, Ascari E.
    Haematologica; 2000 Mar 01; 85(3):263-8. PubMed ID: 10702814
    [Abstract] [Full Text] [Related]

  • 7. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
    Miller TP, Dana BW, Weick JK, Jones SE, Coltman CA, Dahlberg S, Fisher RI.
    Semin Hematol; 1988 Apr 01; 25(2 Suppl 2):17-22. PubMed ID: 2456619
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
    Anderson KC, Skarin AT, Rosenthal DS, MacIntyre JM, Pinkus GS, Case DC, Leonard RC, Canellos GP.
    Cancer Treat Rep; 1984 Nov 01; 68(11):1343-50. PubMed ID: 6209007
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
    Canellos GP, Skarin AT, Rosenthal DS, Moloney WC, Frei E.
    Cancer Treat Rep; 1981 Nov 01; 65 Suppl 1():125-9. PubMed ID: 6173118
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial of high dose cyclophosphamide, vincristine, and prednisone plus or minus doxorubicin (CVP versus CAVP) with long-term follow-up in advanced non-Hodgkin's lymphoma.
    Bishop JF, Wiernik PH, Wesley MN, Kaplan RS, Diggs CH, Barcos MP, Sutherland JC.
    Leukemia; 1987 Jun 01; 1(6):508-13. PubMed ID: 3669768
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
    Federico M, Clò V, Brugiatelli M, Carotenuto M, Gobbi PG, Vallisa D, Lombardo M, Avanzini P, Di Renzo N, Dini D, Baldini L, Silingardi V.
    Haematologica; 1998 Sep 01; 83(9):800-11. PubMed ID: 9825577
    [Abstract] [Full Text] [Related]

  • 12. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma.
    Schmitz N, Kloess M, Reiser M, Berdel WE, Metzner B, Dorken B, Kneba M, Trumper L, Loeffler M, Pfreundschuh M, Glass B, German High-Grade Non Hodgkin's Lymphoma Study Group (DSHNHL).
    Cancer; 2006 Jan 01; 106(1):136-45. PubMed ID: 16331635
    [Abstract] [Full Text] [Related]

  • 13. European experience with ifosfamide in lymphomas.
    von Kalle AK, Schaadt M, Diehl V.
    Semin Oncol; 1989 Feb 01; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M.
    Srp Arh Celok Lek; 1998 Feb 01; 126(9-10):345-8. PubMed ID: 9863405
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of medium and highly malignant non-Hodgkin's lymphoma with combined chemotherapy using methotrexate, adriamycin, cyclophosphamide, vincristine, prednisone and bleomycin (protocol MACOP-B)].
    Pittrová H, Koza V, Vozobulová V, Cetkovský P, Skopek P, Jungerová J, Cepelák V.
    Vnitr Lek; 1989 Dec 01; 35(12):1177-82. PubMed ID: 2483776
    [Abstract] [Full Text] [Related]

  • 16. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V.
    Haematologica; 2000 Feb 01; 85(2):160-6. PubMed ID: 10681723
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T, Tóth E, Molnár Z, Várady E, Deák B, Horváth A, Horváth GI, Eid H, Schneider K, Lovey J, Keresztes S, Esik O, Lengyel Z, Rosta A.
    Orv Hetil; 2004 Dec 12; 145(50):2531-7. PubMed ID: 15662753
    [Abstract] [Full Text] [Related]

  • 18. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
    Shimoyama M, Ota K, Kikuchi M, Yunoki K, Konda S, Takatsuki K, Ogawa M, Tominaga S, Tsugane S, Minato K.
    Jpn J Clin Oncol; 1988 Jun 12; 18(2):113-24. PubMed ID: 3379782
    [Abstract] [Full Text] [Related]

  • 19. Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.
    Costello RT, Zerazhi H, Charbonnier A, de Colella JM, Alzieu C, Poizot-Martin I, Cohen R, Bardou VJ, Xerri L, Olive D, Nezri M, Lepeu G, Gastaut JA.
    Cancer; 2004 Feb 15; 100(4):667-76. PubMed ID: 14770420
    [Abstract] [Full Text] [Related]

  • 20. Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).
    Blayney DW, LeBlanc ML, Grogan T, Gaynor ER, Chapman RA, Spiridonidis CH, Taylor SA, Bearman SI, Miller TP, Fisher RI, Southwest Oncology Group.
    J Clin Oncol; 2003 Jul 01; 21(13):2466-73. PubMed ID: 12829664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.